Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis

M. Manco, M. Marcellini, R. DeVito, D. Comparcola, M. R. Sartorelli, V. Nobili

Research output: Contribution to journalArticle

Abstract

Objective: Our aim was to estimate prevalence of metabolic syndrome (MS), obesity and comorbidities in a cohort of 120 children (3-18 years) with biopsy-proven non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) and to evaluate correlations between clinical or biochemical variables and liver histology. Research methods and procedures: MS was diagnosed according to the adapted National Cholesterol Education Program criteria. Homeostatic model assessment of insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI); and ISI composite, insulin secretion (insulin response at 30 min after a glucose load; HOMA-β cell; insulinogenic index) were all estimated. BMI z-score and total body fat (dual-energy X-ray absorptiometry) were evaluated as indexes of obesity. Results: MS was diagnosed in 66% of children. About 92% had weight above the 85th percentile, of which 42% were obese with weight above 97th percentile. Prevalence of hypertriglyceridaemia was 63%, low HDL cholesterol 45%, hypertension 40% and impaired glucose tolerance 10%. Levels of aminotransferases were higher as the number of comorbidities increased, the highest values being found in subjects with MS (P≤0.05). Prevalence of a grade of steatosis ≥2 (P=0.05) and fibrosis (P≤0.01) was higher in subjects with MS. Histology was associated significantly with higher values of a number of clinical and biochemical parameters (steatosis ≥2 with BMI z-score (P=0.04), fasting insulin (P=0.02), HOMA-IR (P=0.03), Β-cell secretion (P=0.04); necroinflammation with BMI z-score (P=0.007), glucose (P≤0.0001), cholesterol (P≤0.04) and white blood cells (P=0.025); fibrosis with body weight (P=0.05), BMI z-score (P=0.03), cholesterol (P=0.05), triglycerides (P=0.05), fasting insulin (P≤0.0001) and mean values of the hormone at the OGTT (P=0.03), HOMA-IR (P≤0.0001)). Conclusion: Presence of MS or clinical and biochemical variables associated with the syndrome seems to be strictly related to histological features of NASH in paediatric fatty liver disease. Thus, routinely liver biopsy should be encouraged in these children.

Original languageEnglish
Pages (from-to)381-387
Number of pages7
JournalInternational Journal of Obesity
Volume32
Issue number2
DOIs
Publication statusPublished - Feb 2008

Fingerprint

metabolic syndrome
Fatty Liver
histology
Histology
Pediatrics
insulin resistance
liver
Liver
Insulin Resistance
Insulin
insulin
fatty liver
fibrosis
Cholesterol
fasting
biopsy
obesity
Comorbidity
cholesterol
Fasting

Keywords

  • Insulin resistance
  • Insulin secretion
  • Metabolic syndrome
  • Non-alcoholic fatty liver disease (NAFLD)
  • Non-alcoholic steatohepatitis (NASH)

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Public Health, Environmental and Occupational Health
  • Endocrinology
  • Food Science
  • Endocrinology, Diabetes and Metabolism

Cite this

Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. / Manco, M.; Marcellini, M.; DeVito, R.; Comparcola, D.; Sartorelli, M. R.; Nobili, V.

In: International Journal of Obesity, Vol. 32, No. 2, 02.2008, p. 381-387.

Research output: Contribution to journalArticle

Manco, M. ; Marcellini, M. ; DeVito, R. ; Comparcola, D. ; Sartorelli, M. R. ; Nobili, V. / Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. In: International Journal of Obesity. 2008 ; Vol. 32, No. 2. pp. 381-387.
@article{8ca3b73dff554aeb8822afda63a6a7bd,
title = "Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis",
abstract = "Objective: Our aim was to estimate prevalence of metabolic syndrome (MS), obesity and comorbidities in a cohort of 120 children (3-18 years) with biopsy-proven non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) and to evaluate correlations between clinical or biochemical variables and liver histology. Research methods and procedures: MS was diagnosed according to the adapted National Cholesterol Education Program criteria. Homeostatic model assessment of insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI); and ISI composite, insulin secretion (insulin response at 30 min after a glucose load; HOMA-β cell; insulinogenic index) were all estimated. BMI z-score and total body fat (dual-energy X-ray absorptiometry) were evaluated as indexes of obesity. Results: MS was diagnosed in 66{\%} of children. About 92{\%} had weight above the 85th percentile, of which 42{\%} were obese with weight above 97th percentile. Prevalence of hypertriglyceridaemia was 63{\%}, low HDL cholesterol 45{\%}, hypertension 40{\%} and impaired glucose tolerance 10{\%}. Levels of aminotransferases were higher as the number of comorbidities increased, the highest values being found in subjects with MS (P≤0.05). Prevalence of a grade of steatosis ≥2 (P=0.05) and fibrosis (P≤0.01) was higher in subjects with MS. Histology was associated significantly with higher values of a number of clinical and biochemical parameters (steatosis ≥2 with BMI z-score (P=0.04), fasting insulin (P=0.02), HOMA-IR (P=0.03), Β-cell secretion (P=0.04); necroinflammation with BMI z-score (P=0.007), glucose (P≤0.0001), cholesterol (P≤0.04) and white blood cells (P=0.025); fibrosis with body weight (P=0.05), BMI z-score (P=0.03), cholesterol (P=0.05), triglycerides (P=0.05), fasting insulin (P≤0.0001) and mean values of the hormone at the OGTT (P=0.03), HOMA-IR (P≤0.0001)). Conclusion: Presence of MS or clinical and biochemical variables associated with the syndrome seems to be strictly related to histological features of NASH in paediatric fatty liver disease. Thus, routinely liver biopsy should be encouraged in these children.",
keywords = "Insulin resistance, Insulin secretion, Metabolic syndrome, Non-alcoholic fatty liver disease (NAFLD), Non-alcoholic steatohepatitis (NASH)",
author = "M. Manco and M. Marcellini and R. DeVito and D. Comparcola and Sartorelli, {M. R.} and V. Nobili",
year = "2008",
month = "2",
doi = "10.1038/sj.ijo.0803711",
language = "English",
volume = "32",
pages = "381--387",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis

AU - Manco, M.

AU - Marcellini, M.

AU - DeVito, R.

AU - Comparcola, D.

AU - Sartorelli, M. R.

AU - Nobili, V.

PY - 2008/2

Y1 - 2008/2

N2 - Objective: Our aim was to estimate prevalence of metabolic syndrome (MS), obesity and comorbidities in a cohort of 120 children (3-18 years) with biopsy-proven non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) and to evaluate correlations between clinical or biochemical variables and liver histology. Research methods and procedures: MS was diagnosed according to the adapted National Cholesterol Education Program criteria. Homeostatic model assessment of insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI); and ISI composite, insulin secretion (insulin response at 30 min after a glucose load; HOMA-β cell; insulinogenic index) were all estimated. BMI z-score and total body fat (dual-energy X-ray absorptiometry) were evaluated as indexes of obesity. Results: MS was diagnosed in 66% of children. About 92% had weight above the 85th percentile, of which 42% were obese with weight above 97th percentile. Prevalence of hypertriglyceridaemia was 63%, low HDL cholesterol 45%, hypertension 40% and impaired glucose tolerance 10%. Levels of aminotransferases were higher as the number of comorbidities increased, the highest values being found in subjects with MS (P≤0.05). Prevalence of a grade of steatosis ≥2 (P=0.05) and fibrosis (P≤0.01) was higher in subjects with MS. Histology was associated significantly with higher values of a number of clinical and biochemical parameters (steatosis ≥2 with BMI z-score (P=0.04), fasting insulin (P=0.02), HOMA-IR (P=0.03), Β-cell secretion (P=0.04); necroinflammation with BMI z-score (P=0.007), glucose (P≤0.0001), cholesterol (P≤0.04) and white blood cells (P=0.025); fibrosis with body weight (P=0.05), BMI z-score (P=0.03), cholesterol (P=0.05), triglycerides (P=0.05), fasting insulin (P≤0.0001) and mean values of the hormone at the OGTT (P=0.03), HOMA-IR (P≤0.0001)). Conclusion: Presence of MS or clinical and biochemical variables associated with the syndrome seems to be strictly related to histological features of NASH in paediatric fatty liver disease. Thus, routinely liver biopsy should be encouraged in these children.

AB - Objective: Our aim was to estimate prevalence of metabolic syndrome (MS), obesity and comorbidities in a cohort of 120 children (3-18 years) with biopsy-proven non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) and to evaluate correlations between clinical or biochemical variables and liver histology. Research methods and procedures: MS was diagnosed according to the adapted National Cholesterol Education Program criteria. Homeostatic model assessment of insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI); and ISI composite, insulin secretion (insulin response at 30 min after a glucose load; HOMA-β cell; insulinogenic index) were all estimated. BMI z-score and total body fat (dual-energy X-ray absorptiometry) were evaluated as indexes of obesity. Results: MS was diagnosed in 66% of children. About 92% had weight above the 85th percentile, of which 42% were obese with weight above 97th percentile. Prevalence of hypertriglyceridaemia was 63%, low HDL cholesterol 45%, hypertension 40% and impaired glucose tolerance 10%. Levels of aminotransferases were higher as the number of comorbidities increased, the highest values being found in subjects with MS (P≤0.05). Prevalence of a grade of steatosis ≥2 (P=0.05) and fibrosis (P≤0.01) was higher in subjects with MS. Histology was associated significantly with higher values of a number of clinical and biochemical parameters (steatosis ≥2 with BMI z-score (P=0.04), fasting insulin (P=0.02), HOMA-IR (P=0.03), Β-cell secretion (P=0.04); necroinflammation with BMI z-score (P=0.007), glucose (P≤0.0001), cholesterol (P≤0.04) and white blood cells (P=0.025); fibrosis with body weight (P=0.05), BMI z-score (P=0.03), cholesterol (P=0.05), triglycerides (P=0.05), fasting insulin (P≤0.0001) and mean values of the hormone at the OGTT (P=0.03), HOMA-IR (P≤0.0001)). Conclusion: Presence of MS or clinical and biochemical variables associated with the syndrome seems to be strictly related to histological features of NASH in paediatric fatty liver disease. Thus, routinely liver biopsy should be encouraged in these children.

KW - Insulin resistance

KW - Insulin secretion

KW - Metabolic syndrome

KW - Non-alcoholic fatty liver disease (NAFLD)

KW - Non-alcoholic steatohepatitis (NASH)

UR - http://www.scopus.com/inward/record.url?scp=39449100352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39449100352&partnerID=8YFLogxK

U2 - 10.1038/sj.ijo.0803711

DO - 10.1038/sj.ijo.0803711

M3 - Article

C2 - 18087267

AN - SCOPUS:39449100352

VL - 32

SP - 381

EP - 387

JO - International Journal of Obesity

JF - International Journal of Obesity

SN - 0307-0565

IS - 2

ER -